TPG to acquire a 35% stake in SCHOTT Poonawalla from Serum Institute of India.

TPG, a private equity firm, agreed to acquire a 35% stake in SCHOTT Poonawalla, a provider of packaging solutions for the pharmaceutical and biotech industries, from Serum Institute of India, an Indian multinational biotechnology and biopharmaceuticals company. Financial terms were not disclosed. “We are excited to partner with SCHOTT Pharma and Serum Institute of India and build upon SCHOTT Poonawalla’s market leadership position as India’s largest injectables-focused drug containment solutions company. On the back of a world-class manufacturing infrastructure in India, SCHOTT Poonawalla has developed an industry leading reputation by offering a comprehensive product portfolio of the highest quality for over two decades. We look forward to partnering with the senior leadership team as they continue to innovate and improve the quality and standards of pharmaceutical drug containment solutions,” Bhushan Bopardikar, TPG Growth Business Unit Partner.